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Abstract
Background: A non-human primate (NHP) model of gluten sensitivity was employed to study the gene perturbations
associated with dietary gluten changes in small intestinal tissues from gluten-sensitive rhesus macaques (Macaca mulatta).
Methodology: Stages of remission and relapse were accomplished in gluten-sensitive animals by administration of gluten-
free (GFD) and gluten-containing (GD) diets, as described previously. Pin-head-sized biopsies, obtained non-invasively by
pediatric endoscope from duodenum while on GFD or GD, were used for preparation of total RNA and gene profiling, using
the commercial Rhesus Macaque Microarray (Agilent Technologies),targeting expression of over 20,000 genes.
Principal Findings: When compared with normal healthy control, gluten-sensitive macaques showed differential gene
expressions induced by GD. While observed gene perturbations were classified into one of 12 overlapping categories -
cancer, metabolism, digestive tract function, immune response, cell growth, signal transduction, autoimmunity,
detoxification of xenobiotics, apoptosis, actin-collagen deposition, neuronal and unknown function - this study focused
on cancer-related gene networks such as cytochrome P450 family (detoxification function) and actin-collagen-matrix
metalloproteinases (MMP) genes.
Conclusions/Significance: A loss of detoxification function paralleled with necessity to metabolize carcinogens was
revealed in gluten-sensitive animals while on GD. An increase in cancer-promoting factors and a simultaneous decrease in
cancer-preventing factors associated with altered expression of actin-collagen-MMP gene network were noted. In addition,
gluten-sensitive macaques showed reduced number of differentially expressed genes including the cancer-associated ones
upon withdrawal of dietary gluten. Taken together, these findings indicate potentially expanded utility of gluten-sensitive
rhesus macaques in cancer research.
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Introduction
Gluten sensitivity is one of the prominent features of Celiac
disease (CD) which is an autoimmune disorder characterized by
damaged lining of the small intestine due to responses triggered
by dietary gluten, a protein complex found in wheat, rye, and
barley [2]. A series of histopathological manifestations were
described in celiac patients and also in rhesus macaques with
gluten-sensitive enteropathy – a newly established non-human
primate model of gluten sensitivity [1,3,4,5]. In humans, Marsh
[6,7] divided CD-associated lesions, based on severity, into five
categories. In rhesus macaques, lesions were described to range
between mild intraepithelial and lamina propria lymphocytosis
up to almost complete flattening and fusion of the small intestinal
villi, with chronic inflammation of the corresponding lamina
propria [1,5]. Gluten-sensitive macaque model was recently used
to demonstrate the functional changes in intestinal permeability
during the stage of epithelial disrepair caused by dietary gluten. It
was found that at the stage of disrepair, a gluten-derived peptide
such as alpha-2-gliadin 33-mer is capable of penetrating beneath
intestinal epithelium into lamina propria, consistent with findings
described in celiacs [3,4,5,8]. Disrupted pattern of intestinal tight
junctions and deposition of autoantibodies targeting the enzyme
that plays a vital role in gluten digestion i.e. tissue tranglutami-
nase 2 (TG2) in duodenum of macaques with gluten enteropathy
but not in healthy controls was also noted [5].
Despite extensive study of clinical, immunological and histo-
pathological properties of CD, relatively little is known about the
effects of gluten sensitivity on other diseases and their potential
relationship. Lack of knowledge is apparent when trying to study
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another. Underlying genetic predisposition that only began to be
elucidated in gluten-sensitive macaques is another important
component of this complex disease. Due to a growing number of
clinical reports that suggest association between CD and intestinal
T cell lymphomas, adenocarcinomas, diabetes type 1, Autism or
Down syndrome [9,10,11,12,13,14,15,16], it is important to
establish if observations from above studies can also be
demonstrated at the molecular level. Such research should provide
novel leads for existing therapies of not only CD but also
aforementioned diseases. In order to study the selected gene
networks in gluten-sensitive primate host, a quantitative micro-
array gene technology and rhesus macaque model were used. It
was hypothesized that perturbations in cancer-associated gene
networks would be seen in gluten-sensitive animals at the stage of
relapse versus stage of remission. Minimal to no perturbations
induced by dietary gluten changes were expected in normal
healthy control and in gluten-sensitive animals at the stage of
remission.The primary goal was to show that gluten-sensitive
primates respond to dietary gluten changes by up/down-
regulation of selected genes and that such perturbations can be
linked to an increased risk to other diseases such as cancer.
Secondary goal was to determine if withdrawal of dietary gluten is
sufficient to reverse these changes.
Results
Increased levels of plasma AGA and TG2 antibodies in
gluten-sensitive macaques
Withdrawal of dietary gluten resolves in gluten-sensitive
macaques clinical, histopathological as well as immunological
manifestations of the disease including the decline of AGA and
TG2 antibodies in plasma [1,3]. In human patients, combined
presence of AGA and TG2 antibodies is considered to be a highly
accurate predictor of CD [2]. In this study, transition from GFD to
GD was accompanied by significant (p,0.05) increase of both
AGA and TG2 antibodies in gluten-sensitive macaques (Figure 1).
In accord with these and previous reports, the GFD period with
baseline levels of AGA and TG2 antibodies is indicated here as the
stage of immunological remission while the GD period with
significant increase of AGA and TG2 antibodies, is indicated as
the stage of immunological relapse. In normal healthy control
macaques, AGA and TG2 antibodies remained at baseline levels
regardless of the dietary gluten intake.
Differential gene expression in duodenum of gluten-
sensitive macaques
In comparison with normal healthy control, gluten-sensitive
macaques showed an increased number of differentially expressed
genes during the stage of relapse while on GD (Figure 2). Although
all three tested gluten-sensitive animals showed a lower number of
differentially expressed genes during the stage of remission, FH45
macaque was the only one that normalized its gene expression
during the GFD treatment to a baseline level – comparable with
that of a healthy control HK31 (Figure 2). This was not entirely
unexpected, since time needed to accomplish the remission might
substantially differ in between different individuals, as it is
influenced by many physiological and genetic factors [17,18].
Categories of differentially expressed genes
All genes with differential level of expression were further divided
into 12 overlapping categories: 1- cancer, 2- metabolism, 3-
digestive tract function, 4- immune response, 5- cell growth, 6-
signal transduction, 7- autoimmunity, allergy, 8- detoxification of
xenobiotics, 9- apoptosis, 10- not known function, 11- actin-
collagen-MMP gene network, and 12- neuronal function. Three
categories subject to closer examination included: cancer, detoxi-
fication of xenobiotics and actin-collagen-MMP gene network.
Figure 1. AGA and anti-TG2 antibodies in plasma. Plasma antibody responses to gliadin and TG2 were measured in four gluten-sensitive (FH45,
FB97, DJ68 and DE87) and four normal healthy control (HK31, HT24, HD60 and IA24) rhesus macaques at the time of remission and/or relapse. Graph
depicts fold-increases of antibodies over the baseline upon introduction of dietary gluten. Significant (p,0.05) increases are indicated (*).
doi:10.1371/journal.pone.0018648.g001
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PLoS ONE | www.plosone.org 2 April 2011 | Volume 6 | Issue 4 | e18648Figure 2. Differential gene expression. A commercial rhesus-specific gene array was used to measure the differential gene expression in eight
duodenum samples from four selected study macaques: Normal healthy control (HK31), andFH45, FB97 and DJ68 gluten sensitive macaques at the
stages of remission and/or relapse. Absolute numbers of perturbed genes out of ,20,000 tested per each sample are shown.
doi:10.1371/journal.pone.0018648.g002
Figure 3. FH45 macaque. Selected three categories of perturbed genes in duodenum of FH45 gluten-sensitive macaque (normalized against
normal, healthy control macaque HK31) while on gluten diet. Different color shades correspond with four categories of perturbed genes. Similar
patterns of gene perturbation were identified also in FB97 and DJ68 gluten-sensitive macaques (not shown).
doi:10.1371/journal.pone.0018648.g003
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involvement in cancer progression or suppression (Figures 3 and 4).
Since cancer (category 1) genes were represented by two distinct
subcategories i.e. cancer-promoting and cancer-suppressing and
both of these subcategories contained up- and down-regulated
genes, category 1 ended up with less distinct pattern of differential
expression than category 8 or 11 (Figures 4 and 5). Categories 8 and
11 showed predictable pattern of differential expression in all three
gluten-sensitive macaques: While genes responsible for detoxifica-
tion of xenobiotics were predominantly down-regulated during
relapse (Figures 3 and 4D,E, F), genes of actin-collagen-MMP
network were up-regulated (Figures 3 and 4A,B, C).
Impact of dietary gluten withdrawal on differential gene
expression
Although there were similarities in gene expression of three
gluten-sensitive macaques during the relapse stage (Figure 4), there
were also differences during the remission stage(Figure 5). The
most likely explanation for the differences is that despite that all
three gluten-sensitive animals were in immunological remission at
the time of biopsy procedure, the FB97 and DJ68 macaques’
differential gene expressions were not yet at baseline, in spite of
spending 10 weeks on GFD. This was more apparent in case of
DJ68 than in FB97, while complete baseline and no perturbations
were seen in FH45 macaque during the remission stage while on
GFD (Figure 2). Predictably, introduction of dietary gluten
resulted in increase of perturbed genes in three tested gluten-
sensitive animals with DJ68 being the highest (Figures 2 and 5).
Cytochrome P450 family gene network is down-
regulated in gluten-sensitive macaques upon
introduction of dietary gluten
Based on observations with celiac patients who show significant
down-regulation of CYP3A4 gene, a member of the P450 family,
as well as an increased incidence of adenocarcinoma and
lymphoma of the small intestine, it was predicted that gluten-
sensitive macaques would show down-regulation of P450 family
genes while on GD. They were expected to have relatively normal
expression of these genes while on GFD. Differential expression of
P450 gene network in all three gluten-sensitive macaques followed
above prediction. The P450 gene network of FH45 animal is
shown for illustration (Figure 6): Six out of seven perturbed genes
in the P450 network were down-regulated at the stage of relapse in
contrast to only two at the stage of remission. The fact that one
(CYP4B1) gene was up-regulated in FH45 during the stage of
relapse illustrates the complex relationship among factors
associated with gluten sensitivity. Since CYP4B1 metabolizes
carcinogens, its function is especially important in the presence of
multiple cancer-promoting factors.
Actin-collagen-MMP gene network is differentially
expressed in gluten-sensitive macaques upon
introduction of dietary gluten
This network regulates the expression of actin and collagen that
are important for the wound healing process and the scar tissue
formation. An up-regulation of these genes was expected as a
Figure 4. Categories of differentially expressed genes in gluten-sensitive macaques during the relapse stage. 1 – cancer, 2 –
metabolism, 3 – digestive tract function, 4 – immune response, 5 – cell growth, 6 – signal transduction, 7 – autoimmunity, allergy, 8 – detoxification of
xenobiotics, 9 – apoptosis, 10 – not known function, 11 – actin-collagen-MMP network, and 12 – neuronal function. Relative distributions of up-
regulated gene categories are shown in panels A (FH45), B (FB97) and C (DJ68) while down-regulated genes are shown in panels D (FH45), E (FB97)
and F (DJ68).
doi:10.1371/journal.pone.0018648.g004
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caused by chronic inflammatory process and/or auto-immune
reaction in the small intestine. Although FH45 and DJ68 gluten-
sensitive animals showed several of these genes being up-regulated
at the stage of relapse (not shown), the difference with the stage of
remission was not as prominent as it was in case of FB97 where
almost the entire network was perturbed during the stage of
relapse (Figure 7). While actin and collagen differential gene
expression was consistent with expected up-regulation and/or scar
tissue formation, the two key matrix metalloproteinases MMP3
and MMP9 were down-regulated, contradicting the above ‘‘scar
tissue formation’’ hypothesis.
Several disease-associated gene groups are differentially
expressed in gluten-sensitive macaques
In addition to 12 categories of perturbed genes identified in this
study in gluten-sensitive macaques (Figure 4), it was of interest to
identify genes that would link this condition with other diseases
than cancer, as increasingly reported in clinical studies involving
celiacs [9,10,11,12,13,14,15,16]. All three tested gluten-sensitive
macaques showed differential expression of several genes that
could be linked with not only CD but also with Autism, food
allergy, Down Syndrome, Alzheimer Disease, Rheumatoid
Arthritis, Parkinson’s Disease and Muscular Dystrophy (Figure 8).
Although significance of these findings needs to be investigated
further, it provides potentially novel direction for future research
regarding the development of non-human primate models of
above diseases.
Mamu II composition of gluten-sensitive macaques
Although all four gluten-sensitive macaques assigned for this
study had antibodies during the relapse stage against not only
gliadin but also TG2 (autoantigen), their Mamu II (DQA1, DQB1
and DRB) allele composition proved to be not uniform (Table 1).
This possibly indicates that gluten sensitivity is in rhesus macaques
either a) associated with more than one MHC II allele due to a
higher diversity and a broader repertoire of Mamu II than HLA II
[19,20] or b) gluten-sensitivity is in macaques not genetically-
linked with Mamu II. Additional studies are currently in progress
with larger number of gluten-sensitive macaques to elucidate this
issue.
Discussion
A gluten-sensitive rhesus macaque model was used to study the
differential gene expressions induced by GD. In addition, the
potential relationship between gluten sensitivity and cancer was
examined. Although there is growing number of clinical reports
suggesting such relationship in celiac patients, studies that focus on
molecular mechanisms linking these conditions are absent. As
described in earlier reports, administration of GFD or GD to
gluten-sensitive rhesus macaques is associated with absence or
presence of series of the clinical, histopathological, metabolic and
immunological symptoms, collectively referred to as stages of
remission or relapse, respectively [1,3,4,5]. Consistent with our
recent study, gluten-sensitive and control macaques were selected
from the larger cohort of 500 candidate animals based on presence
of plasma AGA and TG2 antibodies [5]. Since combined presence
Figure 5. Dietary gluten withdrawal and differential gene expression. Dietary gluten withdrawal impacts relative distribution of perturbed
gene categories in gluten-sensitive macaques. In three selected categories [1 (cancer), 8 (detoxification of xenobiotics), and 11 (actin-collagen-MMP
network)], these changes included decreased number of ‘‘cancer-promoting’’ events such as down-regulation of category 8 genes and up-regulation
of category 11 genes. Data generated with FB97 and DJ68 macaques during the stage of remission and relapse are shown. FH45 macaque had only
few gene perturbations during the stage of remission while on gluten-free diet, thus relative gene counts are not shown for this animal.
doi:10.1371/journal.pone.0018648.g005
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highly reliable predictor of CD [2,21], it is important to stress that
all four gluten-sensitive macaques in this study had both AGA and
TG2 antibodies. In contrast to our previous work [1,5],
histopathological signs were not used as the predictors of gluten
sensitivity since mucosal damage was not the subject of this study.
Since there is a growing evidence suggesting association between
CD, intestinal cancers and other diseases, we took advantage of the
rhesus macaque model of gluten sensitivity to elucidate A) if such
relationship can be detected on the gene expression level, and B) if
changes in dietary gluten intake influence selected gene expression.
Towards this end, we mainly utilized a rhesus-specific microarray
capable of measuring the expression of over 20,000 genes in one
tissue sample. Differentially perturbed genes were classified into 12
overlapping categories including three main categories of interest:
cancer, detoxification function, and actin-collagen-MMP genes. In
addition, differentially expressed genes that were previously
reported to be associated with various other diseases were also
identified (Figure 8).
The intestinal cytochrome P450 genes such as CYP3A4
participate in metabolism of xenobiotics to reduce their adverse
effects. However, the expression of CYP3A4 in celiac patients is
reduced significantly compared to healthy adults [22,23].
Moreover, CD patients show increased incidence of intestinal
T-cell lymphoma and adenocarcinoma [17,18]. Therefore, the
reduced levels of cytochromes P450 might increase the bioavail-
ability of xenobiotics in celiacs, thereby increasing the incidence of
xenobiotic-induced cancer progression. In order to determine if
above hypothesis can be contemplated in studies with gluten-
sensitive rhesus macaques, expression of cytochrome P450 genes
along with other ‘‘cancer-associated’’ genes was measured in
duodenum biopsies obtained at the stages of remission and relapse.
It was predicted that lack of cytochromes P450 gene expression is
reversed by withdrawal of dietary gluten – by placing the gluten-
sensitive macaques on GFD. Results of this study clearly show that
down-regulation of cytochrome P450 gene network occurs in
gluten-sensitive macaques while on GD. It was also observed that
such down-regulation is ameliorated by GFD treatment although
complete reversal to a level comparable with normal healthy
individual was accomplished only in one out of three gluten-
sensitive macaques tested by microarrays. It is plausible from
generated results that if the gluten-sensitive macaques would be
kept on GFD for a longer period, remaining two animals would
continue reversing cytochrome P450 down-regulation. The
cytochrome P450 gene network down-regulation was paralleled
with overall up-regulation of actin-collagen-MMP gene network.
Consistent with our findings, it was reported that up-regulation of
actin and collagen with simultaneous down-regulation of MMP3
Figure 6. Down-regulation of cytochrome P450 family gene network. Introduction of dietary gluten (relapse stage) down-regulates several
of the genes in P450 network while dietary gluten withdrawal (remission stage) normalizes its expression towards baseline level: Expression in FH45
gluten-sensitive macaque shows 5 out of 6 perturbed genes being more down-regulated during the relapse stage than during the remission stage.
Red signifies up-regulation of a gene while green signifies down-regulation, with the standard level of expression determined by HK31 normal
healthy control macaque. Intensity of color represents the magnitude of change in expression. The solid lines mean that the gene’s protein product
directly affects the target gene’s protein levels, whereas dotted lines mean that the gene’s protein product indirectly alters the target gene’s protein
levels through the involvement of an intermediate gene.
doi:10.1371/journal.pone.0018648.g006
Gene Signatures of Dietary Gluten in Primates
PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e18648and MMP9 occurs as a measure to prevent the cancer formation
in experimentally-treated mice [24]. Since this was observed in
FB97 macaque during relapse, it is likely that gene perturbations
in actin-collagen-MMP network are indicative of a protective
innate response against cancer invasion in at least some of the
gluten-sensitive primates (Figures 3 and 7).
Despite the predictable patterns of differential gene expression
in aforementioned category 8 (detoxification) and 11 (actin-
collagen-MMP) genes, category 1 (cancer) did not follow such
pattern, due to high complexity of gene interactions in this
category, with multiple cancer-promoting and –suppressing genes
being simultaneously affected by dietary gluten changes. Taken
together with category 8 and 11 gene expression results however,
our results indicate that relapse stage of gluten sensitivity in rhesus
macaques is conducive to tumorigenesis and it can be partially
reversed by withdrawal of dietary gluten.
Many questions still remain. Some of these are due to our
incomplete knowledge whether rhesus macaques class II alleles are
associated with gluten sensitivity in a fashion analogous to human
celiac patients i.e. DQ2/8 alleles [2,18,25,26]. Our current model
can only be referred as ‘‘gluten sensitivity’’ model, keeping in mind
that there are at least two categories of gluten sensitivity in primates:
first of which is Mamu II-dependent (CD-like) while second is Mamu
II-independent (food allergy-like). Our results involving the genetic
analysis of 50+ rhesus macaques with and without gluten sensitivity
indicate that a Mamu II-associated predisposition for this condition
exists in rhesus monkeys[Sestak et al., unpublished]. Relatively high
variation in differential gene distribution in this study might thus be
explained by different Mamu II backgrounds in selected gluten-
sensitive animals (Table 1). In order to improve the rhesus model of
gluten sensitivity and to make it more relevant as a CD model,
selection of gluten-sensitive macaques will need to be carried out in
future also in the context of MamuII pre-screening. Our results
indicate that CD, food allergy and other disease condition-
associated genes including the cancer-related ones are differentially
expressed in gluten-sensitive macaques. Finally, results reported
here show that above gene perturbations are ameliorated and even
abrogated by dietary gluten withdrawal. These results can be used
as a platform for future studies aiming at elucidation of relationship
between CD and cancer.
Materials and Methods
Ethics statement
Approval for all veterinary procedures in this study had been
obtained from the Tulane University Animal Care and Use
Committee (Protocol # 3508), Animal Welfare Assurance A-4499-
01. Animals in this project were under the full care of veterinarians
of the Tulane National Primate Research Center in accordance
with the standards incorporated in the Guide to the Care and Use
of Laboratory Animals (NIH) 78-23 (Revised, 1996). All veterinary
procedures were performed only with sedated animals. Animal
welfare and steps were taken to ameliorate suffering in accordance
with the recommendations of the Weatherall report.
Figure 7. Perturbations in the actin-collagen-MMP gene network. Introduction of dietary gluten (relapse stage) up-regulates most of the
actin and collagen genes while MMP3 and MMP9 are down-regulated. Data generated with FB97 gluten-sensitive macaque during the stage of
remission and relapse are shown. Red signifies up-regulation of a gene while green signifies down-regulation, with the standard level of expression
determined by HK31 normal healthy control macaque. Intensity of color represents the magnitude of change in expression. The solid lines mean that
the gene’s protein product directly affects the target gene’s protein levels, where as dotted lines mean that the gene’s protein product indirectly
alters the target gene’s protein levels through the involvement of an intermediate gene.
doi:10.1371/journal.pone.0018648.g007
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Four gluten-sensitive (FH45, DJ68, DE87 and FB97) and four
normal, healthy control (HK31, HT24, HD60 and IA24) rhesus
macaques (Macaca mulatta) of Indian subspecies, 2–9 years of age,
simian retrovirus-free, of either sex were used in this study. Since
prevalence of gluten sensitivity in macaques is similar to that of
humans, gluten-sensitive animals were selected from the larger
cohort of 500 candidates, as described in detail elsewhere [5].
Gluten-sensitive macaques were distinguished from normal,
healthy ones by presence of both anti-gliadin (AGA) and anti-
tissue transglutaminase 2 (TG2) serum antibodies. All gluten-
sensitive animals were kept at least 10 weeks on gluten-free diet
(GFD), followed by 10 weeks of regular, gluten-containing chow
(GD) (PMI Nutrition Intl., St. Louis, MO), to accomplish the stage
of remission and relapse. The transition of GFD to GD was
characterized by significant (p,0.05) increase of AGA and anti-
TG2 serum antibodies above the baseline (Figure 1). In case of
normal healthy control animals, antibody levels were always in
baseline regardless of dietary gluten intake.
Small intestine and peripheral blood sample collection
Two ml of peripheral blood was collected at the stage of
remission and/or relapse from all animals as described [5]. In
addition, sample of distal duodenum (five pin-head sized biopsies)
was collected at the stage of remission and relapse from three
gluten-sensitive animals with highest level of antibody increase
(Figure 1) by pediatric endoscope as described [5]. In case of
healthy control animal (HK31), endoscopy procedure was also
performed twice in parallel with procedures done in gluten-
sensitive animals despite that no relapse stage characterized by
significant antibody increase was present in HK31 in association
with introduction of dietary gluten (Figure 1). All collected biopsy
samples were immediately placed in five ml of RNA-later solution
(Qiagen, Valencia, CA) to preserve the RNA. Blood was processed
Figure 8. DJ68 and FB97 macaques. Selected categories (a. Celiac Disease, b. general gluten sensitivity or inflammation and c. other disease) of
upregulated genes in duodenum of DJ68 and FB97 gluten-sensitive macaques (normalized against normal, healthy control macaque HK31) while on
gluten-containing diet. Different color shades correspond with different categories of perturbed genes.
aTGM2=tissue transglutaminase 2 functions
as celiac disease autoantigen;
bIL17B=IL-17 cytokine reported to be produced in celiacs but not in other gluten-sensitive patients;
cMICB=NKG2D
ligand suggested to mediate the transformation of TCR-dependent CD8+ CTLs to TCR-independent (NK-like) effector IELs in celiac patients;
dIFNg=interferon gamma is produced by T cells and promotes gluten peptide flux across intestinal epithelium;
eITGAE i.e. CD103 antigen was
suggested to mediate the celiac-specific autoimmune response in the small intestine.
doi:10.1371/journal.pone.0018648.g008
Table 1. Composition of Mamu-DQA1, -DQB1 and -DRB alleles of four gluten-sensitive macaques used in this study.
Macaque Mamu-DQA1* Mamu-DQB1* Mamu-DRB
FH45 01:05:01/26:01 06:02:01/18:01 *W6:06,*W21:04,*W26:03/1*03:03:01,1*10:07
DJ68 23:02/26:01 18:04/18:01 *W1:01,*W6:02,*W6:09:01/1*03:03:01,1*10:07
DE87 01:05:01/05:04 06:02:01/17:03 *W6:06,*W21:04*,W26:03/*W20:02:01,*W25:01
FB97 01:02/23:02 06:05/18:04 Not defined
Note: The Mamu-DQA1*, -DQB1* and -DRB alleles were targeted due to their possible involvement in autoimmunity.
doi:10.1371/journal.pone.0018648.t001
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indirect ELISA for the presence of anti-gliadin and anti-TG2
antibodies [1].
RNA isolation, cDNA synthesis
Total RNA was extracted from the intestinal biopsies using the
Qiagen’sRNeasy plus micro kit, following the instructions of
manufacturer. One pin-head-size biopsy out of five collected was
sufficient to isolate the required amount of RNA using the RNeasy
kit.NanoDrop spectrophotometer (Thermo Scientific, Wilming-
ton, DE) was used to measure the RNA concentration and purity.
Total RNA was used to perform the cDNA synthesis and cyanine
dye labeling as described previously [27], using the Agilent Low
RNA Input Linear Amplification-Labeling Kit (LRILAK). The
labeled cDNA was used to perform overnight hybridization to
Agilent’s rhesus macaque whole genome microarray, according to
the manufacturer’s instructions [28].
Microarray procedure and gene expression
A commercially available oligonucleotide rhesus macaque
whole genome Microarray encompassing ,20,000 target genes
(Agilent Technologies, Palo Alto, CA) was used. Arrays were
printed using the 4644 k format (Agilent Technologies). The slides
were washed according to the manufacturer’s instructions and
then imaged using the GenePix Pro 6.1 software. Individual
measurements were recorded in at least two duplicates. The
resulting .gal files were analyzed by SpotfireDecisionSite, Micro-
array Analysis module (TIBCO-Spotfire, Boston MA) as previ-
ously described [28]. Following the removal of unreliable spots, the
data was normalized using a Locally Weighted Scatterplot
Smoothing (LOWESS) algorithm and the resulting ratios of
change in gene-expression captured on a logarithm to two scale
[28]. Each set of differentially expressed genes contained both
‘‘up-regulated’’ and ‘‘down-regulated’’ ones. In compliance with
MIAME guidelines, the raw microarray data associated with this
manuscript will be uploaded to Gene Expression Omnibus
database prior to publication.
Gene function
In order to define and to categorize the function of individual
differentially expressed genes, a web-based program www.
genecards.org (Weizmann Institute of Science, Rehovot, Israel)
was used.
Analysis of rhesus major histocompatibility class II (Mamu
II) composition
Mamu-DRB typing was performed by using a DRB specific
microsatellite (D6S2878) as described recently [29]. DQA1 and
DQB1 alleles have been determined by direct sequencing.
Therefore, polymerase chain reactions (PCR) were performed in
a mixture of 10 ng DNA (DQA1) or 30 ng DNA (DQB1), 16PCR
buffer II (Invitrogen), 5 mMdNTPs, 10 uM of each primer (59
DQA1-intr1b-M13: TGT AAA ACG ACG GCC AGT CCT
GCT TGT CAT CTT CAC TCA and 39 DQA1-GH27: CAC
GGA TCC GGT AGC AGC GGT AGA GTT G for DQA1, 59
DQB1-M13: TGT AAA CGA CGG CCA GTT CCC CGC
AGA GGA TTT CGT G and 39 DQB1-intr 2: TGC GGG CGA
CGACGA CGC CTC ACC TC for DQB1, respectively), 50 mM
MgCl2, and 5 units of Taq polymerase (Invitrogen). The cycling
parameters for the PCR and the sequencing reactions were the
same as described earlier [30]. For allele definition the program
SBT engine (Genome Diagnostics, Utrecht, The Netherlands) was
used. The nomenclature for the Major Histocompatibility
Complex (MHC) genes for non-human primates was described
by Ellis and coworkers [31] and the allele names were given in
accord with recently revised nomenclature for the human MHC
[32].
Statistical analysis
In order to determine if anti-gliadin and anti-TG2 antibody
levels increased significantly after introduction of dietary gluten in
gluten-sensitive animals above the baseline represented by
negative control animals, a Wilcoxon Signed Rank Test with a
significance of p,0.05, was used. The microarray experiments
were designed so as to normalize the gene expression levels in
duodenum samples from gluten-sensitive macaques relative to
those obtained from a normal, healthy, control macaque while on
gluten-free diet. At least two-fold differences in relative expression,
with a significance of p,0.05, were considered differentially
expressed (t-test function in SpotfireDecisionSite, Functional
Genomics module).
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